Polaskey, Meredith T.
Aldredge, Lakshi
Heath, Candrice
Acevedo, Moises
Chu, David H.
Hanna, Diane
Seal, Melissa S.
Zirwas, Matthew
Chovatiya, Raj https://orcid.org/0000-0001-6510-399X
Funding for this research was provided by:
Arcutis Biotherapeutics, Inc.
Article History
Received: 29 August 2024
Accepted: 27 September 2024
First Online: 28 October 2024
Declarations
:
: Meredith T. Polaskey has no disclosures to report. Lakshi Aldredge, Candrice Heath, Moises Acevedo, Matthew Zirwas, and Raj Chovatiya are investigators and/or consultants for Arcutis Biotherapeutics, Inc. and received grants/research funding and/or honoraria. David H. Chu, Diane Hanna, and Melissa S. Seal are employees of Arcutis Biotherapeutics, Inc.
: This study was supported by Arcutis Biotherapeutics, Inc. Thank you to the respondents for their participation in the surveys. Writing support was provided by Lauren Ramsey, PharmD of Alligent Biopharm Consulting LLC, and funded by Arcutis Biotherapeutics, Inc.
: The survey was not reviewed by an ethics committee and because of the nature of the survey and information collected is exempt from this requirement on the basis of the Human Subject Regulations Decision Charts: 2018 Requirements: 45 CFR 46.104(d)(2) for Educational Tests, Surveys, Interviews, or Observation of Public Behavior. The trial was conducted in accordance with the principles of the Declaration of Helsinki of 1964 and its later amendments and Good Clinical Practice guidelines of the International Council for Harmonisation. Not applicable: Before enrollment of patients, the study protocol and informed consent form were reviewed and approved by an appropriate institutional review board or independent ethics committee. Participants provided consent to participate in the survey and for the data to be published in aggregate.